LEONARD M MILSTONE, MD
Dermatology in New Haven, CT

License number
Connecticut 019995
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
800 Howard Ave Yale BUILDING PHYSICIANS, New Haven, CT 06519
Phone
(203) 785-2140
(203) 785-7998
(203) 785-6414 (Fax)

Personal information

See more information about LEONARD M MILSTONE at radaris.com
Name
Address
Phone
Leonard Milstone, age 79
94 Blake Rd, Hamden, CT 06517
(203) 787-0617
Leonard M Milstone, age 80
94 Blake Rd, Hamden, CT 06517
(203) 787-0617
Leonard M Milstone, age 80
94 Blake St, Hamden, CT 06517
(203) 787-0617
Leonard M Milstone
800 Howard St, New Haven, CT 06519
(203) 785-4632
Leonard M. Milstone
New Haven, CT
(203) 787-0617

Organization information

See more information about LEONARD M MILSTONE at bizstanding.com

Yale Dermatology Associate - Leonard M Milstone MD

2 Church St S STE 305, New Haven, CT 06519

Categories:
Dermatology Physicians & Surgeons, Pediatrics Physicians & Surgeons, Physicians & Surgeons
Phone:
(203) 789-1249 (Phone)


Leonard M Milstone MD

800 Howard Ave, New Haven, CT 06519

Industry:
Medical Doctor's Office
Medical Doctors:
Leonard Milstone (Medical Doctor),Milton B. Shields Owner, inactive,Karen M. Sutton Medical Doctor, inactive

Professional information

See more information about LEONARD M MILSTONE at trustoria.com
Leonard Matthew Milstone Photo 1
Leonard Matthew Milstone, New Haven CT

Leonard Matthew Milstone, New Haven CT

Specialties:
Dermatologist
Address:
333 Cedar St, New Haven, CT 06510
2 Church St S, New Haven, CT 06519
Education:
Yale University, School of Medicine - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Molecular Genetics
Yale New Haven Psychiatric Hospital - Residency - Dermatology
OHSU Hospitals & Clinics - Residency - Dermatology
Board certifications:
American Board of Dermatology Certification in Dermatology


Leonard M Milstone Photo 2
Dr. Leonard M Milstone, New Haven CT - MD (Doctor of Medicine)

Dr. Leonard M Milstone, New Haven CT - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
Yale Dermatology Associates
2 Church St S SUITE 305, New Haven 06519
(203) 789-1249 (Phone)
Certifications:
Dermatology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Yale Dermatology Associates
2 Church St S SUITE 305, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Yale University
Graduated: 1970
Oreg
Yale New Haven Hospital
National Institutes Of Health Clinical Center


Leonard Milstone Photo 3
Leonard Milstone, New Haven CT

Leonard Milstone, New Haven CT

Specialties:
Dermatology
Work:
Yale Physicians Practice
800 Howard Ave, New Haven, CT 06519 Yale University
2 Church St S, New Haven, CT 06519 Yale University
333 Cedar St, New Haven, CT 06510
Education:
Yale University (1970)


Leonard Milstone Photo 4
Compositions And Methods For Treating Cutaneous Hyperproliferative Disorders

Compositions And Methods For Treating Cutaneous Hyperproliferative Disorders

US Patent:
5242921, Sep 7, 1993
Filed:
Nov 28, 1991
Appl. No.:
7/783560
Inventors:
Leonard M. Milstone - Hamden CT
Pauline M. Schwartz - Madison CT
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31495, A61K 3150, A61K 31505
US Classification:
514249
Abstract:
The present invention provides new methods for the treatment of hyperproliferative disorders of skin epidermal cells, particularly psoriasis, by administering methotrexate and dipyridamole, with one or both agents being administered topically at the site of the hyperproliferative disease.


Leonard Milstone Photo 5
Method For The Treatment Of Hyperproliferative Disorders

Method For The Treatment Of Hyperproliferative Disorders

US Patent:
5326764, Jul 5, 1994
Filed:
Jun 16, 1993
Appl. No.:
8/077152
Inventors:
Leonard M. Milstone - Hamden CT
Pauline M. Schwartz - Madison CT
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31505
US Classification:
514258
Abstract:
The present invention provides new methods for the treatment of hyperproliferative disorders of skin epidermal cells, particularly psoriasis, by administering 5-fluorouracil and dipyridamole, with one or both agents being administered topically at the site of the hyperproliferative disease.